Literature DB >> 25683293

Determining Health-Related Quality-of-Life Outcomes Using the SF-6D Preference-Based Measure in Patients Following Total Knee Arthroplasty.

Randa K Elmallah1, Jeffrey J Cherian1, Julio J Jauregui1, Manoshi Bhowmik-Stoker2, Walter B Beaver3, Michael A Mont1.   

Abstract

The SF-6D, a health-related quality-of-life measure, assigns value to patients' perception of their health. We determined SF-6D values of 844 TKA patients, deduced clinical relevance of value changes using effect size, and compared these to clinical and functional improvements 6weeks, 3months, and 1 through 5years post-operatively. The SF-6D significantly improved at all follow-ups after 6weeks. The effect size indicated clinical relevance at every follow-up. The KSS improved at all follow-ups (+43, +51, +56, +57, +57 points), and LEAS scores improved at follow-ups after 6weeks (+1 point at 3months, +2 points thereafter), correlating with SF-6D changes. Deducing utility scores facilitates cost analyses, allowing clinicians to deduce quality-adjusted life-years and economic impacts of treatments.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  SF-6D; health-related measure; outcomes; quality of life; total knee arthroplasty

Mesh:

Year:  2015        PMID: 25683293     DOI: 10.1016/j.arth.2015.01.050

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  2 in total

1.  Quality of life after staged bilateral total knee arthroplasty: a minimum five-year follow-up study of seventy-eight patients.

Authors:  Takehiko Sugita; Naohisa Miyatake; Toshimi Aizawa; Akira Sasaki; Masayuki Kamimura; Atsushi Takahashi
Journal:  Int Orthop       Date:  2018-10-10       Impact factor: 3.075

2.  Quality-Adjusted Life Years After Hip and Knee Arthroplasty: Health-Related Quality of Life After 12,782 Joint Replacements.

Authors:  Joseph F Konopka; Yuo-Yu Lee; Edwin P Su; Alexander S McLawhorn
Journal:  JB JS Open Access       Date:  2018-08-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.